Month: August 2020

– Biohaven will receive up to $250 million to fund zavegepant’s development in migraine and non-migraine indications– Royalty Pharma to acquire up to a 3% royalty for zavegepant, a 0.4% royalty of Nurtec™ ODT and success-based milestone payments– Royalty Pharma will purchase new Commercial Launch Preferred Equity from Biohaven for a total of $200 million payable between 2021 and 2024, providing additional funding for its CGRP-targeting franchiseNEW HAVEN, Conn.and NEW YORK, Aug. 07, 2020 (GLOBE NEWSWIRE) — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Royalty Pharma (Nasdaq: RPRX) announced today that Biohaven has secured up to $250 million in funding to advance the company’s CGRP receptor antagonist program through the development of zavegepant (formerly known as vazegepant). The zavegepant program...

ATHENS, Greece, Aug. 07, 2020 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Ausca Shipping Limited, Hong Kong, for one of its Panamax dry bulk vessels, the m/v Melia. The gross charter rate is US$10,000 per day, plus US$500,000 gross ballast bonus, minus a 5% commission paid to third parties, for a period of about eight (8) months to maximum ten (10) months. The charter is expected to commence on August 20, 2020.The “Melia” is a 76,225 dwt Panamax dry bulk vessel built in 2005.This employment is anticipated to generate approximately US$2.75 million of gross revenue for the minimum scheduled period of the time charter.Upon...

FRAMINGHAM, Mass., Aug. 07, 2020 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced updated presentation information for research from the AC5® self-assembling peptide technology platform being presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting. Because of the ongoing pandemic, the conference has been rescheduled to take place from August 11-13, 2020 and will be held virtually.The abstract has been accepted by SAGES, and the underlying research has been selected to be featured in a podium presentation during the Emerging Technology Session. The presentation, “Novel Self-assembling Agent, AC5-GTM, for Use in Submucosal Lifting in...

LYON, Frankreich, Aug. 07, 2020 (GLOBE NEWSWIRE) —Artikel 223-16 der allgemeinen Verordnung der französischen Autorité des Marchés FinanciersLyon – FrankreichNotiert an folgenden Märkten:Euronext Paris von Euronext (Marktsegment C – ISIN-Code: FR0011471135 – Symbol: ERYP) &Nasdaq Global Select Market in den USA (Symbol: ERYP)Website: www.erytech.com

LIONE, Francia, Aug. 07, 2020 (GLOBE NEWSWIRE) — Articolo 223-16 del regolamento generale dell’Autorité des Marchés Financiers franceseLione – FranciaMercati azionari:Euronext Paris da Euronext (Segmento di mercato C – Codice ISIN: FR0011471135 – Simbolo: ERYP) eNasdaq Global Select Market degli Stati Uniti (Simbolo: ERYP)Sito Web: www.erytech.com

LIVERMORE, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) will host a Virtual Analyst Day on Tuesday, August 18, 2020, at 1:30 p.m. Pacific Time. The public is invited to listen to a live webcast of FormFactor’s Analyst Day on the Investors section of the company’s web site at www.formfactor.com.About FormFactor:FormFactor, Inc. (NASDAQ:FORM), is a leading provider of essential test and measurement technologies along the full IC life cycle – from metrology and inspection, characterization, modeling, reliability, and design de-bug, to qualification and production test. Semiconductor companies rely upon FormFactor’s products and services to accelerate profitability by optimizing device performance and advancing yield knowledge. The Company serves customers through its network of facilities in...

RYE BROOK, N.Y., Aug. 07, 2020 (GLOBE NEWSWIRE) — Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) announced today that Clever Leaves Holdings Inc. (“Holdco”) filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary proxy statement of SAMA, in connection with its proposed business combination with Clever Leaves International Inc. (“Clever Leaves” or the “Company”) pursuant to which Holdco, a newly formed holding company, will acquire SAMA and Clever Leaves (the “Business Combination”).Holdco is anticipated to become a NASDAQ-listed public company trading under the ticker symbol “CLVR” with an anticipated initial enterprise value of approximately $255 million. Clever Leaves’ executive management...

GOLETA, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, announced it will present at the Oppenheimer 23rd Annual Virtual Technology, Internet & Communications Conference taking place  August 11-12, 2020.Chairman & CEO George B. Holmes is scheduled to host a virtual fireside chat for registered event attendees, guided by Oppenheimer Senior Semiconductors Research Analyst Richard Schafer, as follows:Oppenheimer 23rd Annual Virtual Technology, Internet & Communications ConferenceEvent: Virtual Fireside ChatDate: Tuesday, August 11, 2020Time: 10:30 a.m. Eastern time (7:30 a.m. Pacific time)Management will also participate in virtual one-on-one meetings throughout...